A 3D microphysiological model designed to mimic motor neuron diseases, enabling robust nerve growth analysis, glial interactions, and preclinical neurotoxicity testing.

This study assesses the impact of four chemotherapy drugs on nerve function using electrophysiology, metabolic assays, and histology.

Discover how automated analysis pipelines enhance the stability and reproducibility of clinical neurotoxicity predictions using a high-throughput cortical organoid platform.

A human iPSC-derived cortical organoid platform, designed for high-throughput, reproducible compound screening.

Evaluate glial cell differentiation within a 3D central nervous system (CNS) model using induced pluripotent stem cell (iPSC)-derived neurons.

In vitro nerve conduction velocity (NCV) testing for evaluating chemotherapy-induced peripheral neuropathy.

Discover Takeda's innovative rat DRG-microglia co-culture model designed to predict peripheral neuroinflammation and neurotoxicity in therapeutic agents.

3D in vitro model mimicking the dorsal root ganglion (DRG) to dorsal horn synapse using human iPSC-derived sensory nerves.

Learn how to evaluate chemotherapy-induced peripheral neuropathy and antibody-drug conjugate effects on sensory neurons and Schwann cells.